What is Liquid biopsy?
Liquid biopsy is a non-invasive diagnostic technique that allows the detection of tumor material by a simple peripheral blood sample. This technique will serve to improve the diagnosis, prognosis and follow-up of any tumor, and estimate its probabilities of metastasis, the event with the greatest clinical impact today in oncology. Liquid biopsy is considered the technology with the greatest potential for impact on the oncology diagnostic market.
Nasasbiotech is developing new approach in the field of liquid biopsy from the analysis of circulating tumor cells (CTC), the circulating tumor DNA (ctDNA) and the extracellular vesicles of the peripheral blood of the patient, which contain proteins, RNA and DNA with which they mediate cellular communication, with special impact on the metastasis process.
The competitive advantage of extracellular vesicles as biomarkers is based mainly on their greater stability and integrity and on their relative abundance associated with the process of tumor progression.